December 22, 2014

The Food and Drug Administration granted accelerated approval to Lynparza (olaparib), a new drug treatment for women with advanced ovarian cancer associated with defective BRCA genes, as detected by an FDA-approved test.

December 22, 2014

The Food and Drug Administration has granted accelerated approval to Opdivo (nivolumab), a new treatment for patients with unresectable (cannot be removed by surgery) or metastatic (advanced) melanoma who no longer respond to other drugs.

December 19, 2014

M.D. Science Lab, manufacturers of Swiss Navy Premium Lubricants, on Thursday unveiled all-new packaging for their brand for mass-market storefronts.

December 19, 2014
Rinovum Women’s Health, a privately held, U.S.-based women’s health company, announced Friday that it has secured $3 million in a series C financing from its existing investor base.
December 18, 2014

The CVS Health Research Institute released a first look at the comparative utilization of two new hepatitis C treatments in the weeks following their respective launches.

December 17, 2014

Ipsen Biopharmaceuticals on Tuesday announced that Somatuline Depot (lanreotide) Injection 120 mg (referred to as Somatuline) was approved by the U.S. Food and Drug Administration for the treatment of gastroenteropancreatic neuroendocrine tumors.

December 17, 2014

PL Developments on Wednesday announced that it has added menopause relief supplement, EstroG-100, to its private-label portfolio.

December 16, 2014

CHS Health Services and Take Care Employer Solutions have launched the new name and brand of their combined company.

December 16, 2014

Dr. Reddy's Labs announced the launch of valganciclovir tablets USP in 450-mg strength. 

 

December 16, 2014

 Greenstone announced the launch of celecoxib — the authorized generic version of Pfizer's Celebrex — to its line of generic pharmaceuticals. 

December 16, 2014

An interest in proactive wellness and proper nutrition is fueling demand for functional foods, Packaged Facts noted Tuesday in a new report.

December 16, 2014

Living Essentials on Monday introduced its new Strawberry Watermelon-flavored Extra Strength 5-hour Energy shot, which also has six regular strength flavors, as well as decaf. 

December 16, 2014

Novartis on Tuesday received approval from the Food and Drug Administration for Signifor long-acting release (pasireotide) for injectable suspension, for intramuscular use. 

 

December 15, 2014

Cardinal Health has introduced a new tool that gives pharmacists the ability to rapidly analyze antibiotic use trends.

December 15, 2014

There’s concerning news about this flu season as, according to a HealthDay News report, fewer than half of Americans still haven’t gotten their flu shot.

December 15, 2014

A study conducted by Cigna and Safeway shows that reference-based pricing can help control lab costs when individuals are supported with education and an online shopping tool.

December 12, 2014

Two MinuteClinic walk-in medical clinics opened on Friday inside CVS/pharmacy stores in Reno and Sparks.

December 11, 2014

Clinicians are more open to utilizing burgeoning healthcare technology as part of their practice, and patients are more receptive to interacting with that technology, according to a new PricewaterhouseCoopers Health Research Institute report released last month titled “Healthcare delivery of the future: How digital technology can bridge the gap of time and distance between clinicians and consumers.”

 
December 11, 2014

Mscripts has built a comprehensive digital pharmacy platform designed to improve adherence and compliance among patients. “Traditionally, we’ve focused on two-way text messaging and mobile applications,” Mark Cullen, Mscripts CEO, told Drug Store News

December 11, 2014

The Food and Drug Administration on Wednesday approved Gardasil 9 for the prevention of certain diseases caused by nine types of human papillomavirus.

December 11, 2014

After a recent spike in the prices charged for some generic drugs led to outcries from pharmacists, patient advocates and federal lawmakers, a report issued last month suggests that drug costs can be controlled if the Food and Drug Administration changes the way it handles reviews and approvals.

 
December 11, 2014

Lupin Pharmaceuticals launched the authorized generic version of Celebrex capsules in 50-, 100-, 200- and 400-mg dosage strengths. 

December 11, 2014

The global market for mHealth is expected to reach $49.1 billion by 2020, according to a recent study by Grand View Research. Monitoring services are expected to remain the dominant and fastest-growing market segment, with market revenue of $1.2 billion in 2012, and an estimated CAGR of 49.7% from 2014 to 2020.

 
December 11, 2014

Mylan on Thursday announced the launch of methocarbamol injection USP, 100 mg.